Inducible cyclooxygenase released prostaglandin mediates immunosuppression in acute phase of experimental Trypanosoma cruzi infection

Experimental Parasitology

Volumn 111, Issue 2, 2005, Pages 71-79

  Michelin, M A ^a   Silva, J S ^b   Cunha, F Q C ^b  

^a Federal School of Medicine   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

COX 2; Cytokines; Immunosuppression; Prostaglandin; Trypanosoma cruzi

Indexed keywords

CONCANAVALIN A; CYCLOOXYGENASE 2; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MELOXICAM; PROSTAGLANDIN; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; SALICYLATE SODIUM; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; EXPERIMENTAL INFECTION; IMMUNOMODULATION; MALE; MORTALITY; MOUSE; NONHUMAN; PARASITEMIA; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROSTAGLANDIN SYNTHESIS; REGULATORY MECHANISM; SPLEEN CELL; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

ACUTE DISEASE; ANIMALS; CELLS, CULTURED; CHAGAS DISEASE; CONCANAVALIN A; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; CYTOKINES; DINOPROSTONE; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; PARASITEMIA; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SODIUM SALICYLATE; SPLEEN; T-LYMPHOCYTES; THIAZINES; THIAZOLES;

ANIMALIA; TRYPANOSOMA CRUZI;

EID: 24644524015     PISSN: 00144894     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exppara.2005.05.001     Document Type: Article

References (59)

1. I.A. Abrahamsohn, and R.L. Coffman Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection Journal of Immunology 155 1995 3955 3963
2. I.A. Abrahamsohn, A.P. da Silva, and R.L. Coffman Effects of interleukin-4 deprivation and treatment on resistance to Trypanosoma cruzi Infection and Immunity 68 2000 1975 1979
3. B.K. al-Ramadi, J. Meissler Jr., D. Huang, and T.K. Eisenstein Immunosuppression induced by nitric oxide and its inhibition by interleukin-4 European Journal of Immunology 22 1992 2249 2254
4. R.A. Argenzio, and J.M. Rhoads Reactive oxygen metabolites in piglet cryptosporidiosis Pediatric Research 41 1997 521 526
5. A.L. Bocca, E.E. Hayashi, A.G. Pinheiro, A.B. Furlanetto, A.P. Campanelli, F.Q. Cunha, and F. Figueiredo Treatment of Paracoccidioides brasiliensis-infected mice with a nitric oxide inhibitor prevents the failure of cell-mediated immune response Journal of Immunology 161 1998 3056 3063
6. M.M. Borges, J.K. Kloetzel, H.F. Andrade, C.E. Tadakoro, P. Pinge-Filho, and I. Abrahamsohn Prostaglandin and nitric oxide regulate TNF-alpha production during Trypanosoma cruzi infection Immunology Letters 63 1998 1 8
7. Z. Brener The behavior of slender and stout forms of Trypanosoma cruzi in the blood-stream of normal and immune mice Annals of Tropical Medicine and Parasitology 63 1969 215 220
8. S. de Barros-Mazon, M.E. Guariento, C.A. da Silva, R.L. Coffman, and I.A. Abrahamsohn Differential regulation of lymphoproliferative responses to Trypanosoma cruzi antigen in patients with the cardiac or indeterminate form of Chagas disease Clinical Immunology 111 2004 137 145
9. M.C. Cerrone, D.M. Ritter, and R.E. Kuhn Effect of antigen-specific T helper cells or interleukin-2 on suppressive ability of macrophage subsets detected in spleens of Trypanosoma cruzi-infected mice as determined by limiting dilution-partition analysis Infection and Immunity 60 1992 489 498
10. G. Ciabattoni, F. Pugliese, M. Spaldi, G.A. Cinotti, and C. Patrono Radioimmunoassay measurement of prostaglandins E2 and F2a in human urine Journal of Endocrinology Investigation 2 1979 173 182
11. K. Cieslik, Y. Zhu, and K.K. Wu Salicylate suppresses macrophage nitric-oxide synthase-2 and cyclo-oxygenase-2 expression by inhibiting CCAAT/enhancer-binding protein-β binding via a common signaling pathway Journal of Biological Chemistry 277 2002 49304 49310
12. E. Cillari, F.Y. Liew, and R. Lelchuk Suppression of interleukin-2 production by macrophages in genetically susceptible mice infected with Leishmania major Infection and Immunity 54 1986 386 394
13. D.S. Cunningham, R.G. Benavides, and R.E. Kuhn Suppression of mitogen-induced blastogenesis by Trypanosoma cruzi-induced suppressor substance Journal of Parasitology 66 1980 722 729
14. G. Engelhardt, R. Bogel, C. Schnitzer, and R. Utzmann Meloxicam: influence on arachidonic acid metabolism. Part 1. In vitro findings Biochemistry and Pharmacology 51 1996 21 28
15. I.M. Fierro, V. Nascimento-Da-Silva, M.A. Arruda, M.S. Freitas, M.C. Plotkowski, F.Q. Cunha, and C. Barja-Fidalgo Induction of NOS in rat blood PMN in vivo and in vitro: modulation by tyrosine kinase and involvement in bactericidal activity Journal of Leukocyte Biology 65 1999 508 514
16. C.G. Freire-de-Lima, D.O. Nascimento, M.B.P. Soares, P.T. Bozza, H.C. Castro-Faria-Neto, F.G. Mello, G.A. Dos Reis, and M.F. Lopes Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages Nature 403 2000 199 203
17. A.P. Galvão da Silva, J.F. Jacysyn, and I. Abrahamsohn Resistant mice lacking interleukin-12 become susceptible to Trypanosoma cruzi infection but fail to mount a T helper type 2 response Immunology 108 2003 230 237
18. A. Harel-Bellan, M. Joskowicz, D. Fradelizi, and H. Eisen T lymphocyte function during experimental Chagas disease: production of and response to interleukin 2 European Journal of Immunology 15 1985 438 442
19. H.R. Herschman Prostaglandin synthase 2 Biochimestry and Biophysic Acta 1299 1996 125 140
20. K. Hiyama, S. Hamano, T. Nakamura, K. Nomoto, and I. Tada IL-4 reduces resistance of mice to Trypanosoma cruzi infection Parasitology Research 87 2001 269 274
21. C. Holscher, M. Mohrs, W.J. Daí, G. Kohler, B. Ryffel, G.A. Schaub, H. Mossmann, and F. Brombacher Tumor necrosis factor alpha-mediated toxic shock in Trypanosoma cruzi-infected interleukin 10-deficient mice Infection and Immunity 68 2000 4075 4083
22. K. Katamura, N. Shintaku, Y. Yoriko, T. Fukui, Y. Ohshima, M. Mayumi, and K. Furusho Prostaglandin E2 priming of naive CD4+ T cells inhibits acquisition of ability to produce IFN-γ and IL-2, but not IL-4 and IL-5 Journal of Immunology 155 1995 4604 4612
23. E. Kopp, and S. Ghosh Inhibition of NF-kB by sodium salicylate and aspirin Science 265 1994 956 959
24. 2 regulates macrophage-derived tumor necrosis factor gene expression Journal of Biological Chemistry 263 1988 5380 5384
25. E. Kuroda, T. Sugiura, K. Zeki, Y. Yoshida, and U. Yamashita Sensitivity difference to the suppressive effect of Prostaglandin E2 among mouse strains: a possible mechanism to polarize Th2 Type response in BALB/c mice Journal of Immunology 164 2000 2386 2395
26. F.Y. Liew, S. Millott, C. Parkinson, R.M. Palmer, and S. Moncada Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from l-arginine Journal of Immunology 144 1990 4794 4797
27. + T cell death by apoptosis in experimental Chagas disease Journal of Immunology 154 1995 744 752
28. G.A. Martins, M.A. Cardoso, J.C. Aliberti, and J.S. Silva Nitric oxide-induced apoptotic cell death in the acute phase of Trypanosoma cruzi infection in mice Immunology Letters 63 1998 113 120
29. R. Matasic, A.B. Dietz, and S. Vuk-pavlovic Cyclooxygenase-independent inhibition of dendritic cell maturation by aspirin Immunology 101 2000 53 60
30. M.A. Michelin, F. Figueiredo, and F.Q. Cunha Involvement of prostaglandins in the immunosuppression occurring during experimental infection by Paracoccidioides brasiliensis Experimental Parasitology 102 2002 170 177
31. J.A. Mitchell, M. Saunders, P.J. Barnes, R. Newton, and M.G. Belvisi Sodium salicylate inhibits cyclo-oxygenase-2 activity independent of transcription factor (nuclear factor kappaB) activation: role of arachidonic acid Molecular Pharmacology 51 1997 907 912
32. C. Moon, M. Ahn, Y. Jee, S. Heo, S. Kim, H. Kim, K. Sim, C. Koh, Y. Shin, and T. Shin Sodium salicylate-induced amelioration of experimental autoimmune encephalomyelitis in Lewis rats is associated with the suppression of inducible nitric oxide synthase and cyclooxygenases Neuroscience Letters 356 2004 123 126
33. + T-cell clones: T helper type 1-like phenotype and reactivity with shed trypomastigote antigens Infection and Immunity 4 1993 3250 3258
34. N. Nogueira, and Z. Cohn Trypanosoma cruzi: mechanism of entry and intracellular fate in mammalian cells Journal of Experimental Medicine 143 1976 1402 1420
35. G.P. O'Neill, B.P. Kennedy, J.A. Mancini, S. Kargman, M. Ouellet, J. Yergey, J.P. Falgueyret, W.A. Cromlish, P. Payette, and C.C. Chan Selective inhibitors of COX-2 Agents and Actions Suppl. 46 1995 159 168
36. R.P. Phipps, R.L. Roper, and S.H. Stein Regulation of B-cell tolerance and triggering by macrophages and lymphoid dendritic cells Immunology Review 117 1990 135 158
37. P. Pinge-Filho, C.E. Tadokoro, and I.A. Abrahamsohn Prostaglandins mediate suppression of lymphocyte proliferation and cytokine synthesis in acute Trypanosoma cruzi infection Cellular Immunology 193 1 1999 90 98
38. C. Ramos, I. Schadtler-Siwon, and L. Ortiz-Ortiz Suppressor cell present in the spleens of Trypanosoma cruzi infected mice Journal of Immunology 122 1979 1243 1247
39. S.G. Reed, C.E. Brownell, D.M. Russo, J.S. Silva, K.H. Grabstein, and P.J. Morrissey IL-10 mediates susceptibility to Trypanosoma cruzi infection Journal of Immunology 153 1994 3135 3140
40. S.G. Reed, C.L. Larson, and C.A. Speer Suppression of cell-mediated immunity in experimental Chagas disease Zeitschrift fur Parasitenkunde 52 1977 11 17
41. N.E. Reiner, and C.J. Malemud Arachidonic acid metabolism by murine peritoneal macrophages infected with Leishmania donovani: in vitro evidence for parasite-induced alterations in cyclooxygenase and lipoxygenase pathways Journal of Immunology 134 1985 556 563
42. S. Revelli, L. Gomez, J. Wietzerbin, O. Bottasso, and M.A. Basombrio Levels of tumor necrosis factor alpha, gamma interferon, and interleukins 4, 6, and 10 as determined in mice infected with virulent or attenuated strains of Trypanosoma cruzi Parasitology Research 85 1999 147 150
43. R.L. Roper, D.H. Corand, D. Briwn, G. Warner, and R.P. Phipps Prostaglandin E2 promotes IL-4 induced IgE and IgG1 synthesis Journal of Immunology 145 1990 2644 2651
44. M. Rottenberg, C. Lindqvist, E. Koman, L. Segura, and A. Orn Modulation of both interleukin 2 receptor expression and interleukin 2 production during experimental murine Trypanosoma cruzi infection Scandinavian Journal of Immunology 30 1989 65 72
45. E.C. Rowland, and R.E. Kuhn Suppression of cellular response in mice during Trypanosoma cruzi infection Infection and Immunity 20 1978 393 397
46. J.S. Silva, D.R. Twardzik, and S.G. Reed Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta) Journal of Experimental Medicine 174 1991 539 545
47. J.S. Silva, G.N. Vespa, M.A. Cardoso, J.C. Aliberti, and F.Q. Cunha Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages Infection and Immunity 63 1995 4862 4867
48. N.M. Silva, W.L. Tafuri, J.I. Alvarez-Leite, J.R. Mineo, and R.T. Gazzinelli Toxoplasma gondii: in vivo expression of BAG-5 and cyst formation is independent of TNF p55 receptor and inducible nitric oxide synthase functions Microbes and Infection 4 2002 261 270
49. W.L. Smith, and D.L. DeWitt Prostaglandin endoperoxide H synthase-1 and -2 Advances in Immunology 62 1996 167 215
50. M.B. Soares, K.N. Silva-Mota, R.S. Lima, M.C. Bellintani, L. Pontes-de-Carvalho, and R. Ribeiro-dos-Santos Modulation of chagasic cardiomyopathy by interleukin-4: dissociation between inflammation and tissue parasitism American Journal of Pathology 159 2001 703 709
51. J. Sternberg, and F. McGuigan Nitric oxide mediates suppression of T cell responses in murine Trypanosoma brucei infection European Journal of Immunology 22 1992 2741 2744
52. G. Strassmann, V. Patil-Koota, F. Finkelman, M. Fong, and T. Kambayahi Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2 Journal of Experimental Medicine 180 1994 2365 2370
53. R.L. Tarleton Trypanosoma cruzi-induced suppression of IL-2 production. II. Evidence for a role for suppressor cells Journal of Immunology 140 1988 2769 2773
54. I. Tegeder, J. Pfeilschifter, and G. Geisslinger Cyclooxygenase- independent actions of cyclooxygenase inhibitors The FASEB Journal 15 2001 2057 2072
55. F. Torrico, H. Heremans, M.T. Rivera, M.E. Van, A. Billiau, and Y. Carlier Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice Journal of Immunology 146 1991 3626 3632
56. R.C. van der Veen, T.A. Dietlin, L. Pen, J.D. Gray, and F.M. Hofman Antigen presentation to Th1 but not Th2 cells by macrophages results in nitric oxide production and inhibition of T-cell proliferation; interferon-γ is essential but insufficient Cellular Immunology 206 2000 125 135
57. T.C.T.M. Van der Pouw Kraan, L.C.M. Boeije, R.J.T. Smeenk, J. Wijdenes, and L.A. Aarden Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production Journal of Experimental Medicine 181 1995 775 779
58. C. Walker, F. Kristensen, F. Bettens, and A.L. deWeck Lymphokine regulation of activated (G1) lymphocytes. I. Prostaglandin E2-induced inhibition of interleukin 2 production Journal of Immunology 130 1983 1770 1773
59. E.C. Yong, E.Y. Chi, and W.R Henderson Jr. Toxoplasma gondii alters eicosanoid release by human mononuclear phagocytes: role of leukotrienes in interferon gamma-induced antitoxoplasma activity Journal of Experimental Medicine 180 1994 1637 1648